Renal Insufficiency, Chronic
-
Subject Areas on Research
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
-
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
-
A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda.
-
A Novel Approach to Developing a Discordance Index for Older Adults With Chronic Kidney Disease.
-
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.
-
A massive pelvic mucocele presenting as a cystic sacral mass.
-
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
-
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia.
-
A rose by any other name: is stage 3a chronic kidney disease really a disease?
-
A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry.
-
A varying patient safety profile between black and nonblack adults with decreased estimated GFR.
-
APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study.
-
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
-
Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
-
Acid Load and Phosphorus Homeostasis in CKD.
-
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
-
Active vitamin D and survival.
-
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.
-
Acute kidney injury and chronic kidney disease after cardiac surgery.
-
Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
-
Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.
-
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Ambulatory blood pressure in chronic kidney disease: do ethnic disparities exist?
-
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
-
An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States.
-
Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
-
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
-
Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
-
Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?
-
Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.
-
Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.
-
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
-
Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults.
-
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
-
Association of Fitness With Racial Differences in Chronic Kidney Disease.
-
Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission.
-
Association of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease.
-
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults.
-
Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
-
Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.
-
Association of functional and structural social support with chronic kidney disease among African Americans: the Jackson Heart Study.
-
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
-
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
-
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
-
Atrial Fibrillation and Risk of ESRD in Adults with CKD.
-
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.
-
Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.
-
Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease.
-
Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly.
-
Brain-kidney cross-talk: Definition and emerging evidence.
-
Branch chain amino acids: biomarkers of health and disease.
-
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.
-
CKD as a Model for Improving Chronic Disease Care through Electronic Health Records.
-
CKD of Uncertain Etiology: A Systematic Review.
-
COVID-19 and the Kidney Community: Coalescing in Crisis.
-
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.
-
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.
-
Cardiorenal interactions: insights from the ESCAPE trial.
-
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
-
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.
-
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
-
Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.
-
Challenges perceived by primary care providers to educating patients about chronic kidney disease.
-
Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial.
-
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.
-
Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function.
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
-
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
-
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.
-
Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.
-
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
-
Chronic kidney disease and recurrent falls in nursing home residents: a retrospective cohort study.
-
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
-
Chronic kidney disease and stroke.
-
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Chronic kidney disease in low- and middle-income countries.
-
Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.
-
Chronic pain and analgesic use in CKD: implications for patient safety.
-
Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
-
Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.
-
Clinical imaging of vascular disease in chronic kidney disease.
-
Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease.
-
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.
-
Common variants in Mendelian kidney disease genes and their association with renal function.
-
Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study.
-
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
-
Comorbidities in Heart Failure: Are There Gender Differences?
-
Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
-
Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
-
Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.
-
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
-
Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
-
Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.
-
Connecting cytokines and cellular signals in the nephron during CKD and hypertension.
-
Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.
-
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
-
Contemporary mineral metabolism for clinicians and scientists: introduction.
-
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
-
Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Correction of anemia with epoetin alfa in chronic kidney disease.
-
Correlates of left ventricular mass in chronic hemodialysis recipients.
-
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
-
Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
-
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
-
DASH Diet and Blood Pressure Among Black Americans With and Without CKD: The Jackson Heart Study.
-
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.
-
Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry.
-
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
-
Depression in patients with chronic kidney disease on dialysis in Saudi Arabia.
-
Development and validation of a cross-cultural knowledge, attitudes, and practices survey instrument for chronic kidney disease in a Swahili-speaking population.
-
Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
-
Device therapy in heart failure patients with chronic kidney disease.
-
Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.
-
Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions.
-
Diabetic kidney disease: a report from an ADA Consensus Conference.
-
Dietary acid load: a novel nutritional target in chronic kidney disease?
-
Dietary and commercialized fructose: Sweet or sour?
-
Disordered FGF23 and mineral metabolism in children with CKD.
-
Disparities in the burden, outcomes, and care of chronic kidney disease.
-
Distribution of survival times in a real-world cohort of older adults with chronic kidney disease: the median may not be the message.
-
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
-
Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy?
-
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care.
-
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
-
Effect of Genetic African Ancestry on eGFR and Kidney Disease.
-
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
-
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
-
Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials.
-
Effect of renal function on antihypertensive drug safety and efficacy in children.
-
Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
-
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial.
-
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
-
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
-
Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.
-
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
-
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
-
Effects of phosphate binders in moderate CKD.
-
Effects of serum creatinine calibration on estimated renal function in african americans: the Jackson heart study.
-
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials.
-
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.
-
Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults.
-
Epidemiology of chronic kidney disease among older adults: a focus on the oldest old.
-
Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance.
-
Estimation of GFR in South Asians: a study from the general population in Pakistan.
-
Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults.
-
Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease.
-
Evaluation of renal function before and after percutaneous mitral valve repair.
-
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
-
Exome-Based Rare-Variant Analyses in CKD.
-
Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation.
-
FGF23 and Left Ventricular Hypertrophy in Children with CKD.
-
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
-
FGF23 modifies the relationship between vitamin D and cardiac remodeling.
-
FGFR4 does not contribute to progression of chronic kidney disease.
-
Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population.
-
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.
-
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
-
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
-
Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
-
Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
-
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
-
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function.
-
Fibroblast growth factor 23 and Inflammation in CKD.
-
Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
-
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
-
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
-
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
-
Fibroblast growth factor-23 and cardiovascular events in CKD.
-
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.
-
Folic acid supplementation and chronic kidney disease progression.
-
Food Access, Chronic Kidney Disease, and Hypertension in the U.S.
-
GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
-
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study.
-
Genetic Abrogation of Adenosine A3 Receptor Prevents Uninephrectomy and High Salt-Induced Hypertension.
-
Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
-
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.
-
Genetic background influences cardiac phenotype in murine chronic kidney disease.
-
Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study.
-
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.
-
HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
-
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
-
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.
-
Health information technology (IT) to improve the care of patients with chronic kidney disease (CKD).
-
Heart failure with preserved ejection fraction: a nephrologist-directed primer.
-
Heavy metal nephropathy: considerations for exposure analysis.
-
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.
-
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
-
Hepcidin and disordered mineral metabolism in chronic kidney disease.
-
High-dose IV iron for anemia correction in chronic kidney disease.
-
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?
-
Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.
-
Hospital discharge communications during care transitions for patients with acute kidney injury: a cross-sectional study.
-
Hospitalizations among adults with chronic kidney disease in the United States: A cohort study.
-
Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes.
-
Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy.
-
ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
-
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.
-
Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
-
Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.
-
Impact of automated reporting of estimated glomerular filtration rate in the veterans health administration.
-
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial.
-
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.
-
Impact of renal dysfunction on acute coronary syndrome evaluation in observation unit patients.
-
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
-
Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study.
-
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.
-
Improving Primary Care for Patients With CKD in the Digital Era.
-
Improving the prediction of hypertensive target organ damage using novel markers: lessons from retinal vascular imaging research.
-
In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia.
-
In reply to 'validating GFR estimating samples with clinical outcomes'.
-
In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
-
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.
-
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
-
Incorporating Geriatric Assessment into a Nephrology Clinic: Preliminary Data from Two Models of Care.
-
Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study.
-
Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.
-
Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.
-
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
-
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
-
Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease.
-
Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.
-
Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.
-
Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
-
Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
-
Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells.
-
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
-
Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.
-
Is chronic kidney disease associated with diabetic retinopathy in Asian adults?
-
Is renal function associated with early age-related macular degeneration?
-
Is there something better than the best marker of kidney function?
-
Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.
-
Kidney developmental effects of metal-herbicide mixtures: Implications for chronic kidney disease of unknown etiology.
-
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
-
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
-
Knowledge, Attitudes, and Practices Associated with Chronic Kidney Disease in Northern Tanzania: A Community-Based Study.
-
Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance.
-
Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study.
-
Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
-
Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population.
-
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.
-
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
-
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.
-
Low use of routine medical care among African Americans with high CKD risk: the Jackson Heart Study.
-
MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration.
-
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.
-
Management of Coronary Disease in Patients with Advanced Kidney Disease.
-
Management of acute coronary syndromes in patients with renal dysfunction.
-
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
-
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
-
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD.
-
Markers of Renal Function in Older Adults Completing a Higher Protein Obesity Intervention and One Year Later: Findings from the MEASUR-UP Trial.
-
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.
-
Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations.
-
Metabolic Changes with Base-Loading in CKD.
-
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014.
-
Mineral metabolites and CKD progression in African Americans.
-
Minithoracotomy versus sternotomy for mitral surgery in patients with chronic renal impairment: a propensity-matched study.
-
Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.
-
Mortality after myocardial infarction: the role of renal function and systolic and diastolic functions of the left ventricle.
-
Nationwide Trends and Variations in Urological Surgical Interventions and Renal Outcome in Patients with Spina Bifida.
-
Neighborhood clustering of non-communicable diseases: results from a community-based study in Northern Tanzania.
-
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.
-
Nephrotoxic contaminants in drinking water and urine, and chronic kidney disease in rural Sri Lanka.
-
New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management.
-
New-onset hypertension and risk for chronic kidney disease in the Japanese general population.
-
Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans.
-
Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study.
-
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
-
Novel Models for Health Care Delivery for CKD for Disadvantaged Populations.
-
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
-
Older Patients' Perspectives on Managing Complexity in CKD Self-Management.
-
Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.
-
Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.
-
Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.
-
Outcomes of Ureteroscopic Stone Treatment in Patients With Spinal Cord Injury.
-
Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.
-
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
-
Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.
-
Patient Education and Support During CKD Transitions: When the Possible Becomes Probable.
-
Patient discourse on chronic kidney disease monitoring: a qualitative study at a Veterans Affairs Renal Clinic.
-
Patient-Reported Safety Events in Chronic Kidney Disease Recorded With an Interactive Voice-Inquiry Dial-Response System: Monthly Report Analysis.
-
Patient-reported and actionable safety events in CKD.
-
Patients' and Nephrologists' Evaluation of Patient-Facing Smartphone Apps for CKD.
-
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
-
Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.
-
Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.
-
Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease.
-
Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study.
-
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
-
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.
-
Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.
-
Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study.
-
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
-
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.
-
Phosphate REINs in the renoprotective benefit of ACE inhibition.
-
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.
-
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
-
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
-
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
-
Plasticity of renal erythropoietin-producing cells governs fibrosis.
-
Postoperative Impact of Diabetes, Chronic Kidney Disease, Hemodialysis, and Renal Transplant After Total Hip Arthroplasty.
-
Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease.
-
Prediction, progression, and outcomes of chronic kidney disease in older adults.
-
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.
-
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).
-
Predictors of length of hospital stay in elderly hip fracture patients.
-
Premature T Cell Senescence in Pediatric CKD.
-
Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.
-
Prevalence and correlates of cardiometabolic multimorbidity among hypertensive individuals: a cross-sectional study in rural South Asia-Bangladesh, Pakistan and Sri Lanka.
-
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry.
-
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.
-
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
-
Prevalence of chronic kidney disease in China.
-
Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010.
-
Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from Tanzania.
-
Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study.
-
Primary Care Physicians' Perceived Barriers to Nephrology Referral and Co-management of Patients with CKD: a Qualitative Study.
-
Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study.
-
Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study.
-
Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study.
-
Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing?
-
Proportion of US adults potentially affected by the 2014 hypertension guideline.
-
Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
-
Pruning the ricket thicket.
-
Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study.
-
Pulmonary Hypertension Subtypes and Mortality in CKD.
-
Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial.
-
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program.
-
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
-
Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.
-
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.
-
Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
-
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
-
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.
-
Recognition of CKD after the introduction of automated reporting of estimated GFR in the Veterans Health Administration.
-
Recycling to discover something new: the role of autophagy in kidney disease.
-
Reducing CKD risks among vulnerable populations in primary care.
-
Regional variation in chronic kidney disease and associated factors in hypertensive individuals in rural South Asia: findings from control of blood pressure and risk attenuation-Bangladesh, Pakistan and Sri Lanka.
-
Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions.
-
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
-
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.
-
Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD.
-
Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.
-
Renal function outcomes after laparoscopic renal cryoablation.
-
Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery.
-
Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function.
-
Retinal Vascular Imaging Markers and Incident Chronic Kidney Disease: A Prospective Cohort Study.
-
Retinal arteriolar narrowing and subsequent development of CKD Stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).
-
Retinal microvascular signs are associated with chronic kidney disease in persons with and without diabetes.
-
Revamping the 'renal' diet: using foods to control phosphorus physiology.
-
Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy.
-
Role of Acid-Base Homeostasis in Diabetic Kidney Disease.
-
SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
-
Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
-
Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.
-
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
-
Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease.
-
Screening for chronic kidney disease.
-
Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.
-
Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Serum Calcification Propensity and Clinical Events in CKD.
-
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.
-
Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes.
-
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.
-
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
-
Setting an agenda for comparative effectiveness systematic reviews in CKD care.
-
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
-
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
-
Socioeconomic status and microalbuminuria in an Asian population.
-
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
-
Specialist and primary care physicians' views on barriers to adequate preparation of patients for renal replacement therapy: a qualitative study.
-
Spirituality, Coping, and Resilience Among Rural Residents Living with Chronic Kidney Disease.
-
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective.
-
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
-
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
-
Statistical methods for building better biomarkers of chronic kidney disease.
-
Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
-
Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients.
-
TRPC Channels in Proteinuric Kidney Diseases.
-
Targeting Fall Risk in CKD.
-
Telehealth Applications to Enhance CKD Knowledge and Awareness Among Patients and Providers.
-
Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
-
The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study.
-
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
-
The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations.
-
The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.
-
The Impact of Chronic Kidney Disease on Postoperative Outcomes in Patients Undergoing Lumbar Decompression and Fusion.
-
The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease.
-
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
-
The association between smoking and long-term outcomes after non-ST-segment elevation myocardial infarction in older patients.
-
The balance of the evidence on acid-base homeostasis and progression of chronic kidney disease.
-
The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy.
-
The chronic kidney disease model: a general purpose model of disease progression and treatment.
-
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
-
The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.
-
The growing burden of chronic kidney disease in Pakistan.
-
The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.
-
The last mile: translational research to improve CKD outcomes.
-
The management of acute coronary syndromes in patients with chronic kidney disease.
-
The need for collaboration to improve cardiovascular outcomes in patients with CKD.
-
The pursuit of truth and beauty.
-
The varying roles of macrophages in kidney injury and repair.
-
Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing.
-
Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis.
-
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
-
Traditional medicine practices among community members with chronic kidney disease in northern Tanzania: an ethnomedical survey.
-
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
-
Trends in Readmission and Costs After Transcatheter Implantation Versus Surgical Aortic Valve Replacement in Patients With Renal Dysfunction.
-
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).
-
Trends in anemia management in US hemodialysis patients 2004-2010.
-
Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
-
Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.
-
Update on fibroblast growth factor 23 in chronic kidney disease.
-
Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
-
Urological complications and vesicoureteral reflux following pediatric kidney transplantation.
-
Usability Testing of a Sick-Day Protocol in CKD.
-
Usability of a CKD educational website targeted to patients and their family members.
-
Usability testing and acceptance of an electronic medication inquiry system for CKD patients.
-
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
-
Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease.
-
Use of a Medical-Alert Accessory in CKD: A Pilot Study.
-
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.
-
Using Zero Balance Ultrafiltration with Dialysate as a Replacement Fluid for Hyperkalemia during Cardiopulmonary Bypass.
-
Using social media to create a professional network between physician-trainees and the American Society of Nephrology.
-
Utility of implantable cardioverter defibrillators in chronic kidney disease.
-
Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
-
Vascular calcification in chronic kidney disease: here to stay?
-
Vitamin D deficiency and anemia in early chronic kidney disease.
-
Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease: If You Are Not Confused, You Are Not Thinking Clearly.
-
We still go for the jugular: implications of the 3SITES central venous catheter study for nephrology.
-
Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4.
-
Keywords of People